A remarkable success story Weiss Korea Opportunity Fund (WKOF) was one of the best-performing of all London-listed investment companies last year, and since its 2013 launch it has delivered more than twice the return of its benchmark. WKOF has a unique investment approach within the investment company sector. Not only is it the only UK-listed […]
A remarkable success story Weiss Korea Opportunity Fund (WKOF) was one of the best-performing of all London-listed investment companies last year, and since its 2013 launch it has delivered more than twice the return of its performance benchmark index, the MSCI Korea 25/50 Index (see page 4). WKOF has a unique investment approach within the […]
A remarkable success story Weiss Korea Opportunity Fund (WKOF) was one of the best-performing of all London-listed investment companies last year, and since its 2013 launch it has delivered more than twice the return of its benchmark. WKOF has a unique investment approach within the investment company sector. Not only is it the only UK-listed […]
Real Estate Roundup Kindly sponsored by Aberdeen Standard Investments Performance data February’s biggest movers in price terms are shown in the chart below. The roadmap out of lockdown and the impressive vaccination programme in the UK has lifted confidence in a swift economic recovery and triggered a shift to value stocks. Property companies on significant […]
Investment Companies Monthly Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Research published over February Polar Capital Global Financials Trust – The tide has turned Having played a supporting role in the initial phase of the stock market recovery – breaking historical precedent in the process – the share prices of financial stocks, and […]
Economic and Political Monthly Roundup Kindly sponsored by Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
In this week’s show, James Carthew talked to Nick Brind from Polar Capital Global Financials Trust. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here. If there is a guest speaker you’d particularly like to hear from, please email us – […]
In this week’s show, James Carthew talked to Nalaka De Silva from Aberdeen Diversified Income and Growth Trust. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here. If there is a guest speaker you’d particularly like to hear from, please […]
On 24th February 2021, QuotedData hosted the final Round the World webinar from our series. This webinar was focused on the UK and included presentations and Q&As from 4 investment companies’ managers, covering markets across the UK. We would like to thank all of our speakers and attendees for joining us. Click on the links below […]
The tide has turned Having played a supporting role in the initial phase of the stock market recovery – breaking historical precedent in the process – the share prices of financial stocks, and banks in particular, have come back sharply since November. Demand for its shares meant that Polar Capital Global Financials Trust’s (PCFT’s) premium […]
The tide has turned Having played a supporting role in the initial phase of the stock market’s recovery – breaking historical precedent in the process – financials, and banks in particular, have performed strongly since November. Polar Capital Global Financials Trust’s (PCFT’s) premium was recently at its highest level in more than five years, paving […]
The tide has turned Having played a supporting role in the initial phase of the market’s recovery – breaking historical precedent in the process – financials, and banks in particular, have come back sharply since November. Polar Capital Global Financials Trust’s (PCFT’s) premium was recently at its highest level in more than five years, paving […]
In this week’s show, James Carthew talked to Matthew Tillett from The Brunner Investment Trust. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here. If there is a guest speaker you’d particularly like to hear from, please email us – […]
On 10th February 2021, QuotedData hosted the penultimate Round the World webinar from our series. This webinar was focused on Asia and included presentations and Q&As from 4 investment companies’ managers, covering markets across Asia. We would like to thank all of our speakers and attendees for joining us. Click on the links below to watch […]
Increasingly diversified as green-led recovery looms JLEN Environmental Assets (JLEN) holds the most diversified portfolio within its peer group. Today, it is asking shareholders to approve a broader definition of environmental assets as well as increased exposure to construction-stage investments. JLEN trades at one of the highest premiums within its peer group. This may reflect its […]
Increasingly diversified as green-led recovery looms JLEN Environmental Assets (JLEN) holds the most diversified portfolio within its peer group. Today, it is asking shareholders to approve a broader definition of environmental assets as well as increased exposure to construction-stage investments. We think that JLEN’s premium, which is one of the highest within its group of […]
Increasingly diversified as green-led recovery looms JLEN Environmental Assets (JLEN) holds the most diversified portfolio within its peer group. Today, it is asking shareholders to approve a broader definition of environmental assets as well as increased exposure to construction-stage investments. We think that JLEN’s premium reflects its asset mix and the accompanying high proportions of […]
In this week’s show, James Carthew talked to Alan Gauld from Standard Life Private Equity Trust. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here. If there is a guest speaker you’d particularly like to hear from, please email us – [email protected]. […]
On 10th February 2021, QuotedData hosted the second of four Round the World webinars. This webinar was focused on the Americas and included presentations and Q&As from 4 investment companies’ managers, covering markets across North and South America. We would like to thank all of our speakers and attendees for joining us. Click on the links […]
Real Estate Roundup Kindly sponsored by Aberdeen Standard Investments Performance data January’s biggest movers in price terms are shown in the chart below. The UK’s vaccination programme has lifted optimism for a speedier opening of the economy than first feared at the start of the year. Property companies that reported positive valuation figures for the […]
Economic and Political Monthly Roundup Kindly sponsored by Allianz A collation of recent insights on markets and economies taken from the comments made by chairmen and investment managers of investment companies – have a read and make your own minds up. Please remember that nothing in this note is designed to encourage you to buy or […]
Investment Companies Monthly Roundup Kindly sponsored by Baillie Gifford and Aberdeen Standard Investments Performance January’s median total share price return from investment companies was (0.2%) (the average was 0.6%), which compares with 4.4% in December 2020. The continued allure of the private companies accessible via the growth capital sector was evident as the year began for […]
A leading biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]
Bold Brilliant biotech investor BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with a […]
Bold Brilliant biotech investor Swiss-listed BB Biotech is the oldest-established, the largest and, over the longer term, one of the best-performing of the small group of closed-end funds that specialise in the biotech sector. It offers investors a vehicle to gain exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, with […]
In this week’s show, James Carthew talked to Dean Orrico from Middlefield Canadian Income. Watch it again here. If you were looking for QuotedData’s roundup of the week’s news, this is now in the news section – just click here If there is a guest speaker you’d particularly like to hear from, please email us – [email protected]. […]
On 3rd February 2021, QuotedData hosted the first of four Round the World webinars. This webinar was focused on Europe and included presentations and Q&As from 3 investment companies’ managers, covering markets across Europe. We would like to thank all of our speakers and attendees for joining us. Click on the links below to watch the […]
On 3rd February 2021, QuotedData hosted the first of four Round the World webinars. This webinar was focused on Europe and included presentations and Q&As from 4 investment companies’ managers, covering markets across Europe. We would like to thank all of our speakers and attendees for joining us. Click on the links below to watch the […]
High yield without compromising on returns 2020 showed off Shires Income’s (SHRS’s) ability to deliver on its objective. By sourcing income from a wider pool than most of its peers, SHRS’s revenue account held up well relative to the wider UK market, and it managed to produce returns ahead of the average of its peers […]
High yield without compromising on returns 2020 showed off Shires Income’s (SHRS’s) ability to deliver on its objective. SHRS’s revenue account held up well relative to the wider UK market, which might be a reflection of it sourcing income from a wider pool than most of its peers. SHRS also managed to produce returns ahead […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
